BJH - 2018, issue Abstract Book BHS, february 2018
C. Gharakhani Nia , S. Calis , Y. Bertrand , L. Achten , J. Soetens , B Casteels , D. Flamez , E. Bollaert , T. Kerre MD, PhD
BJH - volume 8, issue 3, june 2017
T. Kerre MD, PhD
CAR T-cells have revolutionised the treatment of relapsed and refractory B-cell malignancies. Especially in B-ALL, exciting results have been published. This article reviews CAR T-cell design, the optimal T-cell product used, the lymphodepleting regimen preceding the adoptive therapy, successes and toxicities induced by CAR T-cells in clinical trials (especially B cell malignancies), and the future of CARs and their position in the quickly evolving field of targeted therapies and immunotherapy for haematological malignancies.
(BELG J HEMATOL 2017;8(3):94–101)
Read moreBJH - volume 8, issue Abstract Book BHS, february 2017
X. Poiré MD, PhD, C. Graux MD, PhD, A. Ory , J. Jamart , F. Frédéric , H. Schoemans MD, PhD, P. Lewalle MD, PhD, A. De Becker MD, D. Deeren MD, Z. Berneman MD, PhD, T. Kerre MD, PhD, P. Zachée MD, PhD, D. Selleslag MD, Y. Beguin MD, PhD
BJH - volume 8, issue Abstract Book BHS, february 2017
S. Bonte PhD, S. Snauwaert MD, PhD, G. Goetgeluk , B. Vandekerckhove MD, PhD, T. Kerre MD, PhD
BJH - volume 7, issue 2, april 2016
I. Moors MD, L. Noens MD, PhD, T. Kerre MD, PhD
We present the case of a 68 year old woman with multiple myeloma, who developed mild persistent upper and lower gastrointestinal symptoms, together with a rash and abnormal liver function tests, in the early phase post-autologous stem cell transplantation. Pathology findings were compatible with graft-versus-host disease. Local treatment with corticosteroids resulted in a durable remission of the autologous graft-versus-host disease. A literature review reveals an incidence of mild gastrointestinal graft-versus-host disease in 13% of patients after autologous stem cell transplantation. Severe fatal autologous graft-versus-host disease has rarely been reported, and solely in multiple myeloma patients. In this article we discuss incidence, pathophysiology, outcome and treatment of these entities.
(BELG J HEMATOL 2016;7(2):83–6)
Read moreBJH - volume 7, issue 1, february 2016
T. Kerre MD, PhD
(BELG J HEMATOL 2016; 7(1):48–52)
Read moreBJH - volume 7, issue Abstract Book BHS, january 2016
S. Bonte PhD, S. Snauwaert MD, PhD, M. Heemskerk , B. Vandekerckhove MD, PhD, T. Kerre MD, PhD
To provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.